Cargando…
Autophagy inhibition of cancer stem cells promotes the efficacy of cisplatin against non-small cell lung carcinoma
BACKGROUND: Clinical treatment of non-small cell lung carcinoma (NSCLC) by cisplatin eventually results in drug resistance, which cancer stem cells and autophagy are believed to be involved in. In the present study, we aimed to explore the effect of autophagy-inhibited cancer stem cells in NSCLC. ME...
Autores principales: | Hao, Chengcheng, Liu, Guiping, Tian, Guangliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676261/ https://www.ncbi.nlm.nih.gov/pubmed/31368411 http://dx.doi.org/10.1177/1753466619866097 |
Ejemplares similares
-
Silencing of lncRNA XIST inhibits non-small cell lung cancer growth and promotes chemosensitivity to cisplatin
por: Xu, Xiaohui, et al.
Publicado: (2020) -
Aspirin overcomes cisplatin resistance in lung cancer by inhibiting cancer cell stemness
por: Zhao, Maoyuan, et al.
Publicado: (2020) -
Astragaloside IV sensitizes non-small cell lung cancer cells to cisplatin by suppressing endoplasmic reticulum stress and autophagy
por: Lai, Song-Tao, et al.
Publicado: (2020) -
Overexpression of Ulk2 inhibits proliferation and enhances chemosensitivity to cisplatin in non-small cell lung cancer
por: Cheng, Hong, et al.
Publicado: (2019) -
AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumour cells
por: Harhaji-Trajkovic, L, et al.
Publicado: (2009)